Zimmer Biomet wins FDA nod for Sidus stem-free shoulder system

Share

Zimmer Biomet

Zimmer Biomet (NYSE:ZBH) said today it won FDA clearance for its Sidus stem-free shoulder system.

The newly cleared Sidus system is designed as a total shoulder arthroplasty solution for patients with good bone stock with either osteoarthritis, post-traumatic arthrosis, focal avascular necrosis of the humeral head or those who’ve had previous surgeries of the shoulder that don’t compromise fixation, the Warsaw, Ind.-based company said.

“The Sidus stem-free shoulder system offers a novel approach to total shoulder arthroplasty requiring minimal bone resection. The Sidus system is designed to reduce pain and restore range of motion and is clinically proven to help suitable patients,” Dr. Ryan Krupp of Louisville, Ky.’s Norton Orthopedic Specialists said in a prepared statement.

Get the full story on our sister site MassDevice.

Hear from top executives at Abbott, Google, Boston Scientific, Medtronic and more at DeviceTalks Minnesota, June 4–5 in St. Paul.

Speak Your Mind

*